Regulatory

Part:BBa_K5332001:Experience

Designed by: Qilin Yu   Group: iGEM24_NKU-China   (2024-09-21)
Revision as of 11:40, 29 September 2024 by Ieraser (Talk | contribs) (→‎Applications of BBa_K5332001)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K5332001

Many diseases cause local inflammatory reactions in the human body and the concentration of reactive oxygen species in these areas will increase. The parts of the katG promoter base sequence that can efficiently respond to ROS and enable gene transcription can respond well to this environment. When the base fragment is put into the plasmid and then linked to the target gene, once the engineered bacteria reach the inflammation site of the patient, the target gene can immediately respond and be expressed through the katG promoter. In this way, engineered bacteria can achieve the purpose of targeted therapy.

User Reviews

UNIQe1c48f7e6d8a8b64-partinfo-00000000-QINU UNIQe1c48f7e6d8a8b64-partinfo-00000001-QINU